TSPACETHERAPY LIMITED

Executive Summary

TSPACETHERAPY LIMITED shows a stable and healthy financial position typical of a newly incorporated micro-entity with positive net assets and working capital. While current financial health is sound, the company should focus on building reserves and growing revenue to ensure resilience and long-term viability. Early and regular financial monitoring will be key to catching any signs of distress as the business develops.

TSPACETHERAPY LIMITED - Analysis Report

Company Number: 15611294

Analysis Date: 2025-07-29 12:18 UTC

Financial Health Assessment for TSPACETHERAPY LIMITED

---

1. Financial Health Score: B

Explanation:
Given the company’s very recent incorporation (April 2024) and the micro-entity status, the financial metrics available show a stable but very early-stage financial position. The company exhibits a positive net asset position, modest working capital, and no overdue filings, suggesting good initial financial hygiene. However, the scale is small, and the business is in the nascent phase, limiting the scope for a higher grade until more operational history and revenue data emerge.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Assets	483	Indicates liquid or near-liquid resources available to cover short-term obligations. Healthy at this scale.
Current Liabilities	92	Short-term debts are very low, suggesting limited immediate financial pressure.
Net Current Assets	391	Positive working capital ("healthy cash flow buffer") indicating ability to meet short-term liabilities.
Net Assets (Equity)	391	Positive net worth, showing assets exceed liabilities, a "healthy heart" of the company.
Number of Employees	1	Very small operation, reflecting micro-entity scale and low overheads.

---

3. Diagnosis

The company is in a stable early stage with a "healthy cash flow pulse" demonstrated by positive net current assets and net equity. The absence of liabilities beyond the short term and minimal overheads (one employee, the director herself) reduces financial strain. The company structure is straightforward with a single person controlling 75-100% of shares and management, simplifying governance but also concentrating risk.

The financial "symptoms" reflect a start-up in its infancy:

• Limited asset base but no signs of distress or over-leverage.
• No overdue filings, indicating good compliance and management discipline.
• Micro-entity filing exemptions utilized appropriately, showing cost-conscious financial administration.

However, the company’s small scale and very early stage limit its resilience. It lacks diversified income streams and has minimal working capital, which could become a "symptom of distress" if unexpected expenses or revenue shortfalls occur.

---

4. Recommendations

• Build Cash Reserves: Aim to increase current assets (cash or receivables) to strengthen the working capital buffer and absorb operational shocks.
• Revenue Growth Focus: Develop client base and service offerings to increase turnover, enhancing long-term financial sustainability.
• Monitor Overheads Carefully: Maintain low fixed costs relative to income to preserve financial flexibility.
• Regular Financial Reviews: Conduct periodic internal reviews of cash flow and liabilities to quickly identify any emerging financial "symptoms."
• Consider External Funding: If growth plans accelerate, assess options for external funding to avoid financial strain on owner’s equity.
• Compliance Vigilance: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.

---